Home > Income Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Revenue

    Back to Income Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹24,855 Cr₹23,455 Cr₹24,775 Cr₹23,099 Cr₹19,564 Cr

What is the latest Revenue of AUROBINDO PHARMA ?

The latest Revenue ratio of AUROBINDO PHARMA is ₹24,855 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹24,855 Cr
Mar2023₹23,455 Cr
Mar2022₹24,775 Cr
Mar2021₹23,099 Cr
Mar2020₹19,564 Cr

How is Revenue of AUROBINDO PHARMA Trending?

Years Revenue % Change
Mar2024 ₹24,855 Cr
5.97
Mar2023 ₹23,455 Cr
-5.32
Mar2022 ₹24,775 Cr
7.26
Mar2021 ₹23,099 Cr
18.07
Mar2020 ₹19,564 Cr -

Compare Revenue of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹67,294.4 Cr 0.1% 9.5% 4.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,306.0 Cr -2.5% 7.6% 4.7% Stock Analytics
DIVIS LABORATORIES ₹150,343.0 Cr -3% 3.4% 61.5% Stock Analytics
CIPLA ₹117,323.0 Cr -1.6% 3% -3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,619.0 Cr -0.3% 9% 22.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,941.5 Cr -1.2% 2.9% -6.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

0.1%

9.5%

4.2%

SENSEX

-1.8%

2.7%

5%


You may also like the below Video Courses